Compare Advanced Micro Devices (AMD) vs TG Therapeutics Inc (TGTX) Price & Performance

AMD's stock trades at $469.56, down 2.86% over 24 hours, with a bearish technical signal from moving averages but neutral oscillators. The company reported strong Q2 2026 earnings, beating estimates with EPS of $1.66, and shows robust revenue growth, with 2025 revenue reaching $34.64 billion and net income of $4.34 billion. Valuation ratios remain elevated, with a P/E of 121 and P/S of 18.94, reflecting high market expectations amid surging AI demand.

Outlook is supported by AI-driven growth and consistent earnings beats, but risks include intense competition and rich valuations. Analysts maintain a bullish consensus with a $619.54 price target, though near-term volatility may persist due to technical pressure and macroeconomic factors.

TG Therapeutics (TGTX) trades at $49.66, up 1.02% on the day, with a bearish technical signal and recent earnings misses despite strong revenue growth. The company reported Q2 2026 revenue of $240 million and raised full-year BRIUMVI guidance to $950 million, but net income was impacted by manufacturing investments. Valuation ratios show a high P/E of 18.22 and EV/EBITDA of 56.26, while profitability metrics like ROE of 100.28% remain robust.

Outlook is mixed: strong product demand and raised revenue targets support growth, but earnings volatility and a bearish technical trend pose risks. Analyst consensus is bullish with an $63.75 price target, though legal investigations and competitive pressures require monitoring for stock investors.